Mice testes could be used instead of human embryos in stem cell research

clock

Stem cell research: Human embryos may not be needed

Scientists think they may have found an alternative source for stem cell research - a breakthrough that could mean the end of the controversial use of human embryos.

A team of researchers in Germany discovered that isolated cells from mice testes may be just as useful as the stem cells in human embryos.

Publishing the claims in the journal Nature, the scientists, from the Georg August University in Gottingen, believe similar cells could also be extracted from human testicles through a biopsy.

If this is the case, no cloning or destruction of embryos would be necessary.

To perform the research, the team developed a transgenic breed of mouse in which sperm-producing stem cells were labelled with a fluorescent marker. This allowed them to isolate the stem cells in mouse testes.

After culturing the stem cells, they found that some of them looked like embryonic stem cells.

They called these cells multipotent adult germline stem cells (maGSCs).

Like embryonic stem cells, maGSCs can turn into a number of different types of cell including heart, brain and skin cells.

Following this, the team injected the cells into mouse embryos to see whether they could develop inside a living mouse.

In 90% of cases, they did. It is still unclear, however, whether the cells have this capacity under natural conditions inside the testicles.

More work will be needed to test the viability of the cells for the therapy and the group of scientists now plans to repeat the work in humans.

The work is currently only applicable to males.

More on uncategorised

Simplyhealth releases employer guide amid unpaid carer challenges

Simplyhealth releases employer guide amid unpaid carer challenges

Four in five carers with health conditions consider giving up their jobs

Jen Frost
clock 14 November 2024 • 3 min read
Queen Elizabeth II dies after 70 years on the throne

Queen Elizabeth II dies after 70 years on the throne

1926-2022

COVER
clock 08 September 2022 • 1 min read
COVER parent company acquired by Arc

COVER parent company acquired by Arc

Backed by Eagle Tree Capital

COVER
clock 06 April 2022 • 1 min read

Highlights

COVER Survey: Advisers damning of protection insurer service levels

COVER Survey: Advisers damning of protection insurer service levels

"It takes longer than ever to get underwriting terms"

John Brazier
clock 12 October 2023 • 5 min read
Online reviews trump price for young people selecting life and health cover

Online reviews trump price for young people selecting life and health cover

According to latest ReMark report

John Brazier
clock 11 October 2023 • 2 min read
ABI members with staff neurodiversity policy nearly doubles

ABI members with staff neurodiversity policy nearly doubles

Women within executive teams have grown to 32%

Jaskeet Briah
clock 10 October 2023 • 3 min read